Efficacy of Momordica charantia in glycaemic control and insulin resistance among patients with prediabetes and type 2 diabetes. A GRADE-adherent meta-analysis of randomised controlled trials.
- 2025-12
- Review
- Metabolism open 28
- Sphesihle A L Mkhize
- Wendy N Phoswa
- Phikelelani S Ngubane
- Kabelo Mokgalaboni
- PubMed: 41280283
- DOI: 10.1016/j.metop.2025.100407
- Low evidence
- Clinical
The results showed reduced FBG [SMD = -0.46 (-0.73, - 0.18), p = 0.0012]
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes